Latest from Augury Medical
Awards, research milestones, product announcements, and press coverage from Augury Medical.
We're now accepting Early Access requests for the upcoming launch of our flagship product: Navicor. GPs and primary care physicians can sign up to be among the first to use Navicor's guideline-matching engine in their practice, and will contribute directly to ongoing validation.
Request Early Access
Augury Medical has been selected as one of the Top 17 startups for the 2026 W.A. de Vigier Competition, Switzerland's most prestigious award for early-stage companies. We're proud to be recognized among Switzerland's most promising startups as we work toward bringing expert cardiology decision support to primary care.
Read more
Augury Medical joined the Venture Leaders Medtech Boston roadshow in October 2025 as one of Switzerland's top selected medtech startups. The program connected us with investors and partners across the US medtech ecosystem as we advance toward our first commercial launch.
Read more
We're rebranding to Augury Medical! What started as Pace Locator — a name tied to our early work in pacemaker lead optimization — has grown into something broader. Augury Medical better captures our mission: delivering expert cardiology decision support to primary care physicians, and getting patients the right care at the right time.
Augury Medical (formly Pace Locator) has been selected to advance in the Venture Kick programme, one of Switzerland's most competitive startup initiatives. The funding supports continued development of the Navicor clinical decision support platform ahead of its 2026 launch.
Read more
Augury Medical (formerly Pace Locator) has been recognised with the Ypsomed Innovation Prize for its work on closing the cardiology referral gap. The prize acknowledges the clinical impact potential of the Navicor platform and supports the team's fundraising efforts.
Get in touch or request early access to stay close to what we're building.